Article Versions Notes

Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, de Moura Gatti F, Almeida VM, Marana SR, Lopes CD, Tezuka DY, de Albuquerque S, et al. Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design. Pharmaceuticals. 2023; 16(3):428. https://doi.org/10.3390/ph16030428

Ferreira, Glaucio Monteiro, Thales Kronenberger, Vinicius Gonçalves Maltarollo, Antti Poso, Fernando de Moura Gatti, Vitor Medeiros Almeida, Sandro Roberto Marana, Carla Duque Lopes, Daiane Yukie Tezuka, Sérgio de Albuquerque, and et al. 2023. "Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design" Pharmaceuticals 16, no. 3: 428. https://doi.org/10.3390/ph16030428

Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., de Moura Gatti, F., Almeida, V. M., Marana, S. R., Lopes, C. D., Tezuka, D. Y., de Albuquerque, S., da Silva Emery, F., & Trossini, G. H. G. (2023). Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design. Pharmaceuticals, 16(3), 428. https://doi.org/10.3390/ph16030428